Patrick A. Treseler, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Patrick A. Treseler, MD, PhD

Associate Professor, Department of Pathology, UCSF

Phone: (415) 514-1641 (appts)
Box 0102, UCSF
San Francisco, CA 94143-0102

View on UCSF Profiles

Cancer Center Membership

Associate Member ยป Hematopoietic Malignancies

Education

Seattle University, Seattle, WA, B.S., 1975-1979, Biology and Chemistry
Duke University, Durham, NC, M.D. and Ph.D., 1979-1985, Medicine/Immunology
Duke University Medical Center, Durham, NC, 1986, Internal Medicine
Brigham and Women's Hospital, Boston, MA, 1986-1992, Anatomic & Clinical Pathology


Professional Experience

  • 1991-1992
    Dept. of Pathology, Attending Staff Pathologist, Brigham & Women's Hosp., Boston, MA
  • 1992-1995
    Eastside Pathology, Inc., Staff Pathologist, Redmond, WA
  • 1995-present
    Dept. of Pathology, Attending Staff Pathologist and Associate Director of Surgical Pathology, University of California San Francisco, San Francisco, CA

Honors & Awards

  • 1975
    National Merit Scholarship Semi-Finalist and Finalist
  • 1975
    Phi Beta Kappa Outstanding Scholastic Achievement Award
  • 1975
    Bausch and Lomb Honorary Science Award
  • 1975
    American Legion Distinguished Scholastic Achievement Award
  • 1975
    C.R.C. Freshman Chemistry Achievement Award
  • 1978
    Alpha Sigma Nu (National Jesuit Honor Society)
  • 1979
    Seattle University President's Award (Top Graduating Senior)
  • 1979-1985
    Fellow, Duke University Medical Scientist Training Program
  • 1990
    N.I.H. Individual National Research Service Award

Selected Publications

  1. CNS intravascular large cell lymphoma in a patient with autoimmune hemolytic anemia. Neuropathology. 2015 Apr; 35(2):170-4.
    View on PubMed
  2. Vasal injury during inguinal herniorrhaphy: a case report and review of the literature. Perm J. 2014; 18(4):85-8.
    View on PubMed
  3. How I treat CNS lymphomas. Blood. 2013 Oct 3; 122(14):2318-30.
    View on PubMed
  4. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma. Blood. 2013 Jun 6; 121(23):4740-8.
    View on PubMed
  5. Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators. J Cutan Pathol. 2012 Jun; 39(6):651-8.
    View on PubMed
  6. Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. Clin Cancer Res. 2012 Feb 15; 18(4):1146-55.
    View on PubMed
  7. In-transit intramammary sentinel lymph nodes from malignant melanoma of the trunk. Ann Surg. 2012 Jan; 255(1):122-7.
    View on PubMed
  8. Atraumatic splenic rupture: an unusual manifestation of acute HIV infection. AIDS Patient Care STDS. 2011 Aug; 25(8):461-4.
    View on PubMed
  9. Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapy. J Clin Oncol. 2011 Jul 10; 29(20):e595-7.
    View on PubMed
  10. Selective sentinel lymph node dissection for melanoma: importance of harvesting nodes with lower radioactive counts without the need for blue dye. Ann Surg Oncol. 2011 Oct; 18(10):2919-24.
    View on PubMed
  11. Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience. Cancer. 2011 Jan 15; 117(2):250-8.
    View on PubMed
  12. Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer. Breast J. 2009 May-Jun; 15(3):242-6.
    View on PubMed
  13. Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model. Clin Cancer Res. 2009 Mar 15; 15(6):1989-97.
    View on PubMed
  14. Differential gene expression in central nervous system lymphoma. Blood. 2009 Jan 1; 113(1):266-7; author reply 267-8.
    View on PubMed
  15. Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer? J Am Coll Surg. 2008 Dec; 207(6):853-8.
    View on PubMed
  16. Protein biomarker identification in the CSF of patients with CNS lymphoma. J Clin Oncol. 2008 Jan 1; 26(1):96-105.
    View on PubMed
  17. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007 Jul 15; 110(2):695-708.
    View on PubMed
  18. A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer. Surgery. 2006 Dec; 140(6):960-6; discussion 966-7.
    View on PubMed
  19. Molecular pathogenesis of primary central nervous system lymphoma. Neurosurg Focus. 2006; 21(5):E1.
    View on PubMed
  20. Rare oral cavity presentation of a B-cell lymphoblastic lymphoma. A case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jun; 103(6):814-9.
    View on PubMed

Go to UCSF Profiles, powered by CTSI